CDRH Open To Third-Party Review Of 510(k)s With Clinical Data
This article was originally published in The Gray Sheet
Executive Summary
CDRH leadership would not oppose a legislative amendment to allow third parties to review 510(k) applications that rely on clinical data, according to center director David Feigal.
You may also be interested in...
Device Center Director Advocates Getting “Experimental” With Third-Party
The Center for Devices and Radiological Health is looking to assess how third-party and FDA review of 510(k)s compare
Device Center Director Advocates Getting “Experimental” With Third-Party
The Center for Devices and Radiological Health is looking to assess how third-party and FDA review of 510(k)s compare
Third-Party Review Program Must Double Submissions For FDA To Break Even
CDRH predicts a two-fold increase in the third party program's current usage rate will be needed for the system to recoup costs.